Dutch agency invites requests for decentralised procedure slots
This article was originally published in SRA
Executive Summary
Pharmaceutical companies wanting to obtain time slots during the second half of 2010 for submitting marketing authorisation applications under the European Union’s decentralised procedure with the Netherlands as the reference member state should contact the Dutch Medicines Evaluation Board1,2.